Gurgaon Samachar

Digital Biomarker Market Size, Share And Forecast | Key Players – ActiGraph LLC, Akili Interactive Labs, Inc., AliveCor, Inc., Altoida, Inc., Biogen Inc., ConnectedLife Health Pte Ltd

 Breaking News
  • No posts were found

Digital Biomarker Market Size, Share And Forecast | Key Players – ActiGraph LLC, Akili Interactive Labs, Inc., AliveCor, Inc., Altoida, Inc., Biogen Inc., ConnectedLife Health Pte Ltd

April 15
01:31 2022
Digital Biomarker Market Size, Share And Forecast | Key Players – ActiGraph LLC, Akili Interactive Labs, Inc., AliveCor, Inc., Altoida, Inc., Biogen Inc., ConnectedLife Health Pte Ltd
Research Nester
The global digital biomarker market is segmented by application into wellness, disease diagnosis, personalized medication and drug discovery and development.

Research Nester published a report titled “Digital Biomarker Market: Global Demand Analysis & Opportunity Outlook 2030″which delivers detailed overview of the global digital biomarker market in terms of market segmentation by system component, by therapeutic area, by application, development status and by end user. Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

As per the data provided by the Alzheimer’s Association, by the year 2050, around 12.7 Million people aged 65 and older are estimated to have Alzheimer’s dementia.

Alzheimer’s disease represents a rapidly growing burden in the healthcare ecosystem. Although digital biomarkers are slowly finding application in various health conditions such as high blood pressure and sleep apnea, they are presently highly preferred for tracking neurodegenerative disorders. Several organizations are focused on developing digital platforms to remotely collect data from smartphones and wearable devices to track subtle changes in behavior, which will further help detect the disease. Moreover, the Biomarkers for Alzheimer’s Disease Summit, a digital forum, is dedicated to solving the problem of developing clinically validated markers for the early detection of Alzheimer’s. The global digital biomarker market accounted for USD 1,043.3 Million in 2019 and is estimated to grow at a CAGR of 41.22% during the forecast period, i.e., 2020-2030. The market is further expected to reach USD 46,131.4 Million by the end of 2030.

Access PDF to Get More Insights and [email protected] https://www.researchnester.com/sample-request-3217

The global digital biomarker market is segmented by application into wellness, disease diagnosis, personalized medication and drug discovery and development. Among these segments, the drug discovery and development estimated to grow with the highest CAGR of around 42.13% and is estimated to be the leading revenue generating segment by attaining a value of USD 16732.40 Million by the end of 2030.

Geographically, the global digital biomarker market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, out of which, the market in the North America market is projected to grow with a CAGR of 40.13% during the forecast period. Increasing burden of chronic diseases in the region, followed by the rise in smartphone usage are some of the major factors expected to contribute to the market growth.

However, the fact that all the healthcare information cannot be identified, captured, and used, is anticipated to pose as a major risk to the growth of the market. Additionally, lack of interoperability standards and poorly implemented regulations can hinder the seamless exchange of health data, which is further expected to act as a barrier to the growth of global digital biomarker market over the forecast period.

Do You Have Any Query Or Specific Requirement? Ask to Our [email protected] https://www.researchnester.com/ask-the-analyst/rep-id-3217

This report also provides the existing competitive scenario of some of the key players of the global digital biomarker market which includes company profiling of ActiGraph LLC, Akili Interactive Labs, Inc., AliveCor, Inc., Altoida, Inc., Biogen Inc., ConnectedLife Health Pte Ltd, Cambridge Cognition Ltd, Evidation Health, Inc., Fitbit, Inc., Happify, Inc., Human API, GlaxoSmithKline plc, Huma, IXICO plc, Kinsa Inc., Koneksa, Medical Care Corporation, Mindstrong Health, Koninklijke Philips N.V., Neurotrack Technologies, Inc., Novartis AG, ResMed, F. Hoffmann-La Roche Ltd, Winterlight Labs, Verily Life Sciences LLC, and others.

The profiling enfolds key information of the companies which comprises of business overview, products and services, key financials and recent news and developments. Conclusively, the report titled “Digital Biomarker Market: Global Demand Analysis & Opportunity Outlook 2030”, analyses the overall global digital biomarker industry to help new entrants to understand the details of the market. In addition to that, this report also guides existing players looking for expansion and major investors looking for investment in the global digital biomarker market in the near future.    

Access PDF to Get More Insights and [email protected] https://www.researchnester.com/sample-request-3217 

Media Contact
Company Name: Research Nester
Contact Person: Ajay Daniel
Email: Send Email
Phone: +1 646 586 9123
Address:77 water Street, 8th Floor,
City: New York
State: New York 10005
Country: United States
Website: https://www.researchnester.com/reports/digital-biomarker-market/3217